Tin tức & Cập nhật

Chỉ hiển thị Multimedia

Biliary atresia universal screening cost-effective only at certain thresholds

11 Oct 2022

Of various universal screening modalities for biliary atresia, the stool colour card and direct bilirubin (DB) measurements prove to be cost-effective depending on willingness-to-pay thresholds (WTP), a new Japan has found.

11 Oct 2022

Dimethyl fumarate bests interferon β-1a in paediatric-onset multiple sclerosis

10 Oct 2022

The use of dimethyl fumarate (DMF) in the treatment of children with paediatric-onset multiple sclerosis (POMS) appears to produce more favourable effects than interferon β-1a (IFNβ-1a), with those on DMF being less likely to have new or newly enlarging lesions and experience relapse, according to data from the open-label CONNECT study.

10 Oct 2022

Boys born to moms with GDM at risk of neurodevelopmental delays

10 Oct 2022

Neurodevelopment appears to be significantly delayed at up to 4 years of age in boys who are born to mothers with gestational diabetes mellitus (GDM), reports a recent study.

10 Oct 2022

Self-image, physical activity affect life quality in JIA

07 Oct 2022 bởi

In young adults with juvenile idiopathic arthritis (JIA), the most common factors said to significantly influence quality of life (QOL) are physical activity, work/school, fatigue, and self-image, reports a study.

07 Oct 2022

Respiratory support does not improve outcomes in preemies with irregular breathing

07 Oct 2022 bởi

Among very preterm infants who fail to demonstrate regular breathing during deferred cord clamping, breathing support through intermittent positive pressure ventilation (IPPV) is safe but has no impact on transfusion rates or clinical outcomes, according to a recent study.

07 Oct 2022

Robot-assisted laparoscopic pyeloplasty tied to better recovery in kids

06 Oct 2022

For the treatment of ureteropelvic junction obstruction (UPJO) in infants and young children, robotic-assisted laparoscopic pyeloplasty (RALP) leads to less trauma and better recovery while reaching comparable efficacy as conventional LP, a recent study has found.

06 Oct 2022

Original New Drug Application Approvals by US FDA (16 - 30 Sep 2022)

06 Oct 2022

New drug applications approved by US FDA as of 16-30 Sep 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

06 Oct 2022